Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company OGD2 Pharma S.A.S.
DescriptionHumanized mAb targeting the o-acetylated form of ganglioside GD2 (GD2)
Molecular Target Ganglioside GD2 (GD2)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationNeuroendocrine tumors
Indication DetailsTreat neuroblastoma
Regulatory Designation EU - Orphan Drug (Treat neuroblastoma)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today